Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001193125-25-267057

Principal Accounting Officer sold 524 shares at $13.51 ($7,079)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Breedlove Robert Charles Principal Accounting Officer 2025-11-03 Sale −524 $13.51 $7,079 47,407 D: show line 1 in the form
Open-market sales · 524 sh · avg $13.51 · $7,079
Loading xslF345X05/ownership.xml…